As of June 2, 2025, Rhythm Biosciences Ltd (RHY.AX) reports a ROE (Return on Equity) of -790.71%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Rhythm Biosciences Ltd's ROE (Return on Equity)
Over recent years, Rhythm Biosciences Ltd's ROE (Return on Equity) has shown a stable trend. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2024-06-30 | -790.71% |
| 2023-06-30 | -139.89% |
| 2022-06-30 | -119.28% |
| 2021-06-30 | -387.40% |
| 2020-06-30 | -218.28% |
This gradual decrease highlights how Rhythm Biosciences Ltd manages its efficiency in generating profits from shareholders' equity over time.
Comparing Rhythm Biosciences Ltd's ROE (Return on Equity) to Peers
To better understand Rhythm Biosciences Ltd's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Rhythm Biosciences Ltd (RHY.AX) | -790.71% |
| ACN 167 748 843 Ltd (FFC.AX) | 26.88% |
| Vitura Health Ltd (CAU.AX) | 23.17% |
| I'rom Group Co Ltd (2372.T) | 11.08% |
| Sonic Healthcare Ltd (SHL.AX) | 6.46% |
| Apiam Animal Health Ltd (AHX.AX) | 4.04% |
Compared to its competitors, Rhythm Biosciences Ltd's ROE (Return on Equity) is lower than all peers, which may indicate less effective deployment of shareholders' capital.